• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄胎的诊断与外科治疗

Diagnosis and Surgical Treatment of Hydatidiform Mole.

作者信息

Braga Antônio, Chagas Marcela, Asrani Manisha, Soares Juliana Pereira, Sun Sue Yazaki, Araujo Júnior Edward, Mattar Rosiane, Amim Junior Joffre, Rezende-Filho Jorge, Horowitz Neil S, Berkowitz Ross S

机构信息

Department of Gynecology and Obstetrics, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro 22240-003, RJ, Brazil.

Department of Maternal and Child Health, School of Medicine, Fluminense Federal University, Niterói 24070-090, RJ, Brazil.

出版信息

Diagnostics (Basel). 2025 Aug 18;15(16):2068. doi: 10.3390/diagnostics15162068.

DOI:10.3390/diagnostics15162068
PMID:40870919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12386084/
Abstract

Hydatidiform mole is a trophoblastic disorder resulting from abnormal fertilization. Diagnosis is established through a combination of clinical findings, elevated serum human chorionic gonadotropin (hCG) levels, and characteristic features on transvaginal ultrasound. Timely and accurate diagnosis is essential for initiating prompt treatment and preventing medical complications. Uterine evacuation, preferably via vacuum aspiration, is the treatment of choice due to its high efficacy and safety profile. Adjunctive techniques, such as hysteroscopy and intraoperative ultrasonography, enhance the safety and effectiveness of uterine evacuation and should be available to patients, especially at specialized referral centers equipped to manage this diagnosis. In selected cases, particularly in women with fulfilled reproductive goals or those at a high risk of developing post-molar gestational trophoblastic neoplasia (GTN), total abdominal hysterectomy is appropriate. Postoperative follow-up with serial measurements of hCG is essential for monitoring remission and for the early detection of post-molar GTN, which develops in approximately 20% of cases of complete molar pregnancies and 1-4% of partial molar pregnancies. This article provides a comprehensive review of the diagnosis of hydatidiform mole and the surgical techniques employed in the treatment of this condition, emphasizing individualized care and the use of appropriate surgical strategies to treat complications associated with this trophoblastic disease.

摘要

葡萄胎是一种由异常受精引起的滋养层疾病。通过结合临床症状、血清人绒毛膜促性腺激素(hCG)水平升高以及经阴道超声的特征性表现来确诊。及时准确的诊断对于启动及时治疗和预防医疗并发症至关重要。子宫排空,最好通过真空吸引,因其高效和安全的特点是首选的治疗方法。辅助技术,如宫腔镜检查和术中超声检查,可提高子宫排空的安全性和有效性,并且应为患者提供,特别是在具备处理该诊断能力的专业转诊中心。在某些特定情况下,特别是对于已实现生育目标的女性或发生葡萄胎后妊娠滋养细胞肿瘤(GTN)风险较高的女性,全腹子宫切除术是合适的。术后连续测量hCG进行随访对于监测缓解情况以及早期发现葡萄胎后GTN至关重要,GTN在大约20%的完全性葡萄胎妊娠病例和1 - 4%的部分性葡萄胎妊娠病例中发生。本文全面综述了葡萄胎的诊断以及治疗该疾病所采用的手术技术,强调个体化护理以及使用适当的手术策略来治疗与这种滋养层疾病相关的并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/2564ee86779e/diagnostics-15-02068-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/35a184795238/diagnostics-15-02068-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/5c5c93d1db14/diagnostics-15-02068-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/14263f46bc5e/diagnostics-15-02068-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/9592e24fd93d/diagnostics-15-02068-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/0e871e79d99a/diagnostics-15-02068-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/df0b014d57d6/diagnostics-15-02068-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/5a668c7e084c/diagnostics-15-02068-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/123f20c02cc6/diagnostics-15-02068-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/2564ee86779e/diagnostics-15-02068-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/35a184795238/diagnostics-15-02068-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/5c5c93d1db14/diagnostics-15-02068-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/14263f46bc5e/diagnostics-15-02068-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/9592e24fd93d/diagnostics-15-02068-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/0e871e79d99a/diagnostics-15-02068-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/df0b014d57d6/diagnostics-15-02068-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/5a668c7e084c/diagnostics-15-02068-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/123f20c02cc6/diagnostics-15-02068-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7d9/12386084/2564ee86779e/diagnostics-15-02068-g009.jpg

相似文献

1
Diagnosis and Surgical Treatment of Hydatidiform Mole.葡萄胎的诊断与外科治疗
Diagnostics (Basel). 2025 Aug 18;15(16):2068. doi: 10.3390/diagnostics15162068.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Immunohistochemical Staining: Prognostic Marker of Malignant Transformation of Hydatidiform Mole (HM).免疫组织化学染色:葡萄胎(HM)恶性转化的预后标志物。
J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):365-370. doi: 10.1007/s13224-024-02002-7. Epub 2024 Jul 23.
4
Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.预防性化疗用于葡萄胎以预防妊娠滋养细胞肿瘤。
Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD007289. doi: 10.1002/14651858.CD007289.pub3.
5
Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.预防性化疗用于葡萄胎以预防妊娠滋养细胞肿瘤。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD007289. doi: 10.1002/14651858.CD007289.pub2.
6
Combined analysis of clinical features, human chorionic gonadotropin (hCG) value, and hCG ratios for early prediction of postmolar gestational trophoblastic neoplasia.结合临床特征、人绒毛膜促性腺激素(hCG)值及 hCG 比值用于葡萄胎后妊娠滋养细胞肿瘤的早期预测。
Arch Gynecol Obstet. 2023 Apr;307(4):1145-1154. doi: 10.1007/s00404-022-06785-w. Epub 2022 Sep 18.
7
Etiology, Natural History, and Management of Recent Advances in Molar Pregnancy.葡萄胎的病因、自然史及近期进展的管理
Obstet Gynecol. 2025 Oct 1;146(4):451-465. doi: 10.1097/AOG.0000000000005998. Epub 2025 Jul 10.
8
Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades.美国某地区滋养细胞疾病中心过去20年中完全性葡萄胎和部分性葡萄胎的临床表现
Int J Gynecol Cancer. 2016 Feb;26(2):367-70. doi: 10.1097/IGC.0000000000000608.
9
The diagnostic value and accuracy of ultrasound in diagnosing hydatidiform mole: A systematic review and meta-analysis of the literature.超声在诊断葡萄胎中的诊断价值和准确性:文献的系统评价和荟萃分析。
Radiography (Lond). 2022 Nov;28(4):897-905. doi: 10.1016/j.radi.2022.06.005. Epub 2022 Jul 1.
10
Beckwith-Wiedemann Syndrome贝克威思-维德曼综合征

本文引用的文献

1
Etiology, Natural History, and Management of Recent Advances in Molar Pregnancy.葡萄胎的病因、自然史及近期进展的管理
Obstet Gynecol. 2025 Oct 1;146(4):451-465. doi: 10.1097/AOG.0000000000005998. Epub 2025 Jul 10.
2
Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD)-European Society of Gynaecologic Oncology (ESGO)-Gynecologic Cancer InterGroup (GCIG)-International Society for the Study of Trophoblastic Diseases (ISSTD).妊娠滋养细胞疾病治疗实用指南:欧洲滋养细胞疾病治疗组织(EOTTD)-欧洲妇科肿瘤学会(ESGO)-妇科癌症国际协作组(GCIG)-国际滋养细胞疾病研究学会(ISSTD)合作制定
J Clin Oncol. 2025 Jun 20;43(18):2119-2128. doi: 10.1200/JCO-24-02326. Epub 2025 May 13.
3
Rare complications of complete hydatidiform molar pregnancy: the 'hook effect' and thyrotoxicosis.完全性葡萄胎妊娠罕见并发症:“钩状效应”和甲状腺毒症。
BMJ Case Rep. 2024 Oct 1;17(10):e259812. doi: 10.1136/bcr-2024-259812.
4
The causal relationship between hydatidiform mole and nutrients: A two-sample Mendelian randomization study.葡萄胎与营养物质之间的因果关系:一项双样本孟德尔随机化研究。
Clin Nutr ESPEN. 2024 Dec;64:100-106. doi: 10.1016/j.clnesp.2024.09.018. Epub 2024 Sep 27.
5
Future Directions for Gestational Trophoblastic Disease.妊娠滋养细胞疾病的未来方向。
Hematol Oncol Clin North Am. 2024 Dec;38(6):1265-1276. doi: 10.1016/j.hoc.2024.08.019. Epub 2024 Sep 24.
6
Pathology of Gestational Trophoblastic Disease (GTD).妊娠滋养细胞疾病(GTD)的病理学。
Hematol Oncol Clin North Am. 2024 Dec;38(6):1191-1217. doi: 10.1016/j.hoc.2024.08.017. Epub 2024 Sep 24.
7
ACOG Clinical Practice Update: Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of Gestation.美国妇产科医师学会临床实践更新:妊娠 12 周内流产或妊娠丢失后 RhD 免疫球蛋白的应用。
Obstet Gynecol. 2024 Dec 1;144(6):e140-e143. doi: 10.1097/AOG.0000000000005733. Epub 2024 Sep 10.
8
Epidemiology of Gestational Trophoblastic Disease.妊娠滋养细胞疾病的流行病学。
Hematol Oncol Clin North Am. 2024 Dec;38(6):1173-1190. doi: 10.1016/j.hoc.2024.07.003. Epub 2024 Sep 5.
9
Diagnosis and Management of Molar Pregnancies.《胎块性妊娠的诊断与处理》
Hematol Oncol Clin North Am. 2024 Dec;38(6):1149-1159. doi: 10.1016/j.hoc.2024.07.001. Epub 2024 Sep 5.
10
Contraceptive use following gestational trophoblastic disease: A systematic review.妊娠滋养细胞疾病后避孕方法的使用:系统评价。
Contraception. 2024 Sep;137:110488. doi: 10.1016/j.contraception.2024.110488. Epub 2024 May 17.